Quality of life in patients with metastatic breast cancer receiving either docetaxel or sequential methotrexate and 5-fluorouracil. A multicentre randomised phase III trial by the Scandinavian Breast Group
Titel:
Quality of life in patients with metastatic breast cancer receiving either docetaxel or sequential methotrexate and 5-fluorouracil. A multicentre randomised phase III trial by the Scandinavian Breast Group
Auteur:
Hakamies-Blomqvist, L Luoma, M.-L Sjöström, J Pluzanska, A Sjödin, M Mouridsen, H Østenstad, B Mjaaland, I Ottosson-Lönn, S Bergh, J Malmström, P.-O Blomqvist, C